The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible ...

Older adults are being warned against receiving the chikungunya vaccine before traveling. The Ixchiq vaccination, developed ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...